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COMMENTARY
Triumph and/or Tragedy: The Present Food and Drug
Administration Program of Enriching Grains With
Folic Acid
Robert L. Brent, MD, PhDa, Godfrey P. Oakley, Jr, MD, MSPMb
aDepartment of Pediatrics, Radiology, and Pathology, Thomas Jefferson University, Alfred I. duPont Hospital for Children, Wilmington, Delaware; bDepartment of
Epidemiology, Rollins School of Public Health of Emory University, Atlanta, Georgia
Financial Disclosure: Dr Brent owns no stock in companies that make or distribute folic acid or sell or distribute grains. Some of his research that is supported by the National Institutes of Health has dealt with
the use of folic acid to prevent neural tube defects as well as the metabolism of folic acid and methionine. Dr Oakley is a co-inventor of a patent that covers adding folic acid to contraceptive pills (while at the
Centers for Disease Control and Prevention, compensation, if any, will be under the regulations of the Centers for Disease Control and Prevention) and has been a consultant to Ortho McNeil on this issue.
IN THIS ISSUE of Pediatrics, Bol et al1 report on thesurvival and severity of neural tube defects (NTDs)
during the period that the Food and Drug Administra-
tion (FDA) mandated folic acid fortification of grains.
They conducted a retrospective cohort study of 2841
infants with spina bifida and 638 infants with an en-
cephalocele born between 1995 and 2001. The investi-
gators reported that the 5-year survival of 92.1% of
infants born with spina bifida was improved significantly
when compared with the 90.3% survival in infants born
before folic acid fortification. The clinical impact of these
data is that the 5-year mortality from spina bifida de-
creased from 93 to 79 per 1000 spina bifida births. These
data indicate that a child born with spina bifida in the
United States is 10 times as likely to die in the first 5
years as the average newborn child. The survival of
infants born with encephaloceles was higher also during
the fortification period, but the difference was not sta-
tistically significant. The authors concluded that folic
acid fortification “may play a role in reducing the sever-
ity of NTDs” in addition to the prior publications that
indicate that folic acid prevents the occurrence of NTDs.
This is a well-planned and well-performed study. The
investigators’ conclusions are biologically plausible. They
indicate that there may be confounding factors that af-
fect the data, that is, the variable frequency and deci-
sions for interrupting pregnancy because of the presence
of an NTD, the use of historical controls, improvement in
medical and surgical care, and the possible effect of
differences of delivery on the mortality of the infants
with NTDs. The authors do not believe that in utero
surgical intervention had a significant impact on their
data. After considering all these possible confounding
factors, the authors determined that their conclusions
are valid, namely, that the mortality of infants with
NTDs had decreased and the severity of NTDs was re-
duced during the postfortification period. These are rea-
sonable conclusions based on the data.
The investigators also concluded: “As survival rates of
NTD-affected infants improve, health care, education
and family support must expand to meet their needs.” It
is the last sentence of their conclusions that prompted
the title of this commentary, “Triumph and/or Tragedy.”
Although reduction in mortality is good, it is a shortfall
when compared with full prevention. Is it not a tragedy
that we are not preventing all spina bifida that our
current knowledge permits? We have failed to create the
political will, force, and enthusiasm to prevent the oc-
currence of folic acid–preventable spina bifida and anen-
cephaly in a single state, much less the whole country.
In 2000, Brent et al2 published a commentary in
Pediatrics concerning the FDA’s program3 of enriching
Abbreviations: NTD—neural tube defect; FDA—Food and Drug Administration;
CDC—Centers for Disease Control and Prevention
Opinions expressed in this commentary are those of the author(s) and not necessarily those
of the American Academy of Pediatrics or its Committees.
www.pediatrics.org/cgi/doi/10.1542/peds.2005-2557
doi:10.1542/peds.2005-2557
Accepted for publication Oct 17, 2005
Address correspondence to Robert L. Brent, MD, PhD, Department of Pediatrics, Radiology, and
Pathology, Thomas Jefferson University, Alfred I. duPont Hospital for Children, Box 269, Wilmington,
DE 19899. E-mail: rbrent@nemours.org
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275). Copyright © 2006 by the
American Academy of Pediatrics
930 BRENT and OAKLEY
 by Robert Brent on April 11, 2006 www.pediatrics.orgDownloaded from 
grains to prevent folic acid–preventable NTDs. The com-
mentary suggested that the amount of folic acid man-
dated by the FDA was too low. This commentary was in
response to the Stevenson et al4 article published in the
same issue of Pediatrics,5 which clearly supported the
concept that folic acid can prevent NTDs. However, the
Stevenson et al study demonstrated that if the program
were not all-inclusive, many newborns would be born
with NTDs that could have been prevented.
Evidence of the protective effect of folic acid was old
news. Wald et al5 first provided unambiguous evidence
that synthetic folic acid in a pill would prevent children
from developing spina bifida and anencephaly in 1991.
Since 1991, pediatricians have built the political will and
implemented immunization programs that have elimi-
nated Haemophilus influenza B meningitis and croup and
have prevented most cases of pediatric AIDS in this
country. However, we have failed to communicate this
tragic story of children continuing to be born with a
preventable disease. Sufficient folic acid fortification of
foods eaten by women of reproductive age would pre-
vent almost all folic acid–preventable spina bifida and
anencephaly. Berry et al6 demonstrated that adequate
amounts of folic acid dramatically reduced the incidence
of NTDs in China in 1999.
As described in the September 2005 issue of Pediatrics,
Williams et al7 at the Centers for Disease Control and
Prevention (CDC) and in state health departments
tracked the continuing occurrence of spina bifida and
anencephaly before and after folic acid fortification of
“enriched” grains. Although their study definitely dem-
onstrated that the incidence of NTDs was decreased after
fortification, it also indicated that preventable NTDs
were filling hospital rooms and wheel chairs. It is a tragic
failure of public policy, both in the United States and
around the world, that a single case of folic acid–pre-
ventable spina bifida and anencephaly occurs. In 2005,
we published a second commentary8 in the same issue
containing the Williams et al article. As mentioned pre-
viously, we brought this urgent problem to the attention
of the FDA and the world medical community in a
commentary in Pediatrics in 20002 that has been ignored.
The title of that commentary was “The Unnecessary
Epidemic of Folic Acid–Preventable Spina Bifida and
Anencephaly.”2 Unfortunately, it is not a few cases here
and there. The CDC estimates that 2000 cases of folic
acid–preventable spina bifida and anencephaly pregnan-
cies continue to occur yearly in the United States.9 There
are 200 000 children each year around the world born
with these preventable birth defects. We must do better
for children everywhere.
The Bol et al1 article is a stern reminder that, although
the severity of spina bifida may have decreased with
fortification, too many children continue to develop
spina bifida because our enriched grains do not have
enough folic acid. If we double our concentration from
140 to 280 g of folic acid per 100 g of grain, we would
be fortifying at the level recommended in the United
Kingdom by an expert committee and at the level per-
mitted in Australia and New Zealand. It would be
slightly less than the concentration used in Chile, but
women in Chile eat more wheat. Doubling the concen-
tration would be safe and would prevent a higher pro-
portion of preventable spina bifida cases. This accom-
plishment would improve the lives of children and
families and reduce the number of women who would
face the difficult decision that results from the prenatal
diagnosis of spina bifida and anencephaly. In the future
we may need to do more than double the concentration
of folic acid in grains to attain the ultimate goal. Increas-
ing the concentration of synthetic folic acid in flour is
attainable now and is an urgent, essential initial step for
improving child health in the United States.
It is of interest that the 2 NTD epidemiology publica-
tions in 20051,7 for which we have prepared the 2 Pedi-
atrics commentaries did not demand that the concentra-
tion of folic acid be increased. In fact, neither of these
publications raised the issue of the underenrichment of
folic acid in enriched grains. It is important to remember
that when we see a child with spina bifida, the most
likely etiology is that the mother was not consuming
flour that had been sufficiently enriched with folic acid.
We should be as shocked and surprised by the sight of a
child with an NTD in our hospital as we would be by
seeing a child with poliomyelitis.
When research provides the knowledge that enables
society to prevent serious diseases, we should fully im-
plement effective prevention programs. If we do not,
why do we do research? Not only do discoveries that
prevent disease save children’s lives, but the research
can save medical care dollars. Our task should be to get
the prevention to the “bedside” as rapidly as possible.
We have done better than Europe in preventing folic
acid–preventable spina bifida, but we need to implement
programs that prevent all the spina bifida and anenceph-
aly that can be prevented by folic acid. We urge our
pediatric and obstetric colleagues, who know the impact
of spina bifida and anencephaly on the child and his or
her family, and organizations such as the American
Academy of Pediatrics (AAP), American Medical Associ-
ation, American Pediatric Society, the March of Dimes,
and the Spina Bifida Association of America to petition
the FDA to increase the concentration of folic acid re-
quired in all enriched grains. Given that the Institute of
Medicine’s Food and Nutrition Board has recommended
that all who are 50 years and older should consume 2.4
g of synthetic vitamin B12, we encourage the American
Medical Association and AAP to petition the FDA to
require enough vitamin B12 in flour as well.
In the mean time, we should persuade all women of
reproductive age to consume 400 g of folic acid, which
is widely available in multivitamin supplements and in
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many breakfast cereals. Data released, as we write this
commentary, demonstrate that we have made little, if
any, progress in increasing consumption of multivita-
mins in the United States. Only 30% of women of
reproductive age consume folic acid voluntarily. These
data from the March of Dimes survey, published by the
CDC in the Morbidity and Mortality Weekly Report, are yet
another current reminder that full prevention of folic
acid–preventable birth defects is attainable.10 We must
immediately increase the folic acid concentration in en-
riched grains, because these products are consumed by
almost all women of reproductive age.
The prevention of spina bifida and anencephaly that
has occurred as a result of folic acid fortification has
saved the country approximately $250 million dollars
per year in medical care costs. Thus far, this saved
money has not been reinvested in the CDC’s birth-
defects budget. We urge the US Congress to increase the
CDC’s birth-defects budget by $200 million so that it can
have the resources it needs to lead the campaign for the
sustainable elimination of folic acid–preventable spina
bifida and anencephaly, not only in the United States
but also throughout the world. The effective leadership
that the CDC has shown in the global polio-eradication
program suggests that, with resources similar to those
available for polio eradication, that CDC can be effective
in the total prevention of folic acid–preventable birth
defects. The successful prevention of all of these birth
defects will improve the lives of children and, at the
same time, save even more money and resources.
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